The effects of intraoperative hydroxyethyl starch infusion on the short-term prognosis in surgical gastric cancer patients

the effects of intraoperative hydroxyethyl starch infusion on the short-term of patients

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14004073

Enrollment

Unknown

Registered

2014-01-11

Start date

2014-01-01

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gastric cancer

Interventions

two:hydroxyethyl starch infusion

Eligibility

Sex/Gender

All

Age

30 Years to 65 Years

Inclusion criteria

Inclusion criteria: 60 ASA I to II grade gastric cancer patients receiving radical gastrectomy under general anesthesia

Exclusion criteria

Exclusion criteria: cardiopulmonary disorders, liver or(and) kidney insufficiency, infection, abnormal white blood cell counts or abnormal nertophil WBC counts, hemoglobin less than 100g/L.

Design outcomes

Primary

Measure	Time frame
Preoperatiave and one day postoperative peripheral;	—

Contacts

Public ContactDing Zheng-nian

The First affiliated Hospital of Nanjing Medical University

dingzhengnian@sina.com+86 13951086005

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026